ALR Technologies SG Ltd. is a data management company, which engages in providing healthcare management solutions. The company employs 6 full-time employees The company went IPO on 2000-03-13. The company has developed a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA-compliant Diabetes Solution product that collects data from blood glucose meters (BGM) and continuous glucose monitoring device (CGM); a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. From this technology portfolio, the Company has developed the Diabetes Solution product for human health, and the GluCurve product for animal health. The firm is focused on the enhancement of adherence to disease and healthcare management programs through artificial intelligence, machine learning, patient monitoring, and improved communications. Its primary business markets are healthcare providers, the providers of health insurance, and the providers of disease and care management services, including the home care industry.
Follow-Up Questions
Who is the CEO of ALR Technologies SG Ltd?
Mr. Soongling Chan is the Chairman of the Board of Directors of ALR Technologies SG Ltd, joining the firm since 2011.
What is the price performance of ALRTF stock?
The current price of ALRTF is $0.0132, it has decreased 0% in the last trading day.
What are the primary business themes or industries for ALR Technologies SG Ltd?
ALR Technologies SG Ltd belongs to Health Care industry and the sector is Health Care
What is ALR Technologies SG Ltd market cap?
ALR Technologies SG Ltd's current market cap is $8.3M
